CLINICAL LABORATORY MOLECULAR DIAGNOSTICS FOR INFECTIOUS DISEASE MARKETS: Strategies and Trends, Forecasts by Application and Country with Market Analysis & Executive Guides 2023 to 2027
Publication date: July 2023
The Molecular Diagnostics Infectious Disease sector of the clinical diagnostics industry is poised for further growth. A market that just keeps on growing but is becoming more complex and segmented. Find out what’s happening in this informative report and understand the impact of multiplex assays which threaten to change diagnosis and treatment forever.
Infectious disease testing directly benefits from the explosion in biotechnology, especially genomics. Learn all about it in this latest report edition. A range of dynamic trends are pushing market growth and company valuations, including:
- Multiplex testing
- Pathogen evolution and pandemics
- Biotechnology advances in genetics
- Climate change
- The rise of rapid testing
Exciting technical developments especially in the seesaw between nucleic acid testing and immunoassay, hold the promise of a dynamic, growing and evolving world market with diagnostics taking the lead in infectious disease eradication.
The report includes a complete list of Current United States Medicare Fee Payment Schedules to help sharpen your pricing along with the most frequently used and billed tests.
- Blood-borne virus
- Hospital Acquired Infection
- COVID-19 Singleplex
- South Korea
ABOUT THE LEAD AUTHOR
Mr. Greg Powell, B.SC., M.B.A is the President of Howe Sound Research. He is an experienced business and clinical professional and co-author of the paper "The Radioimmunoassay of Angiotensinogen by Antibody Trapping." He has worked in laboratory testing and management for over 20 years. Mr. Powell is a member of The American Association for Clinical Chemistry. Mr. Powell’s education includes:
- B.Sc. (Chemistry) University of BC
- M.B.A. (Finance and Policy) University of BC
- Market Research Seminar - Burke Institute
- Finance for Senior Executives - Harvard Business School